Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Fibrosis and Oncostatin M, with related work in Pathogenesis, Osteopontin, Basal (medicine). Notable publications include 'TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis', 'Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis', and 'Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population'.
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population
The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF)
Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis